Close Menu

NEW YORK (GenomeWeb) – UK prenatal testing firm Yourgene Health said late last week that it has completed the acquisition of Delta Diagnostics, which trades under the name Elucigene Diagnostics.

Yourgene had said earlier this month that it was planning to acquire Elucigene for £9.2 million ($12 million) in cash and stock. Both companies are located in Manchester, UK.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
03

This webinar will provide an overview of how an international reference laboratory has implemented an automated next-generation sequencing workflow with custom panels for analyzing cancer samples.

Oct
10

This webinar will provide an overview of how a pathology laboratory validated a 77-gene next-generation sequencing-based liquid biopsy assay.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.